Question
ASCVD, CKD, chronic kidney disease
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, EVENTS, ASCVD
Among adults older than 65 years with chronic kidney disease (CKD) stages 3 to 4 and no history of atherosclerotic cardiovascular disease (ASCVD), is new statin use associated with lower risk of mortality or major adverse cardiovascular events (MACE)?